Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Cijfers eurocastle 2012
Volgen
Heren wat is dit????????????? Cijfers van 2012www.4-traders.com/EUROCASTLE-INVEST-2...
EUROCASTLE INVEST. : Preliminary Results, Amendment to Convertible Securities & Management Agreement and New Investment Focus 02/28/2013| 02:05am US/Eastern EUROCASTLE INVESTMENT LIMITED FOR IMMEDIATE RELEASE Contact: International Administration Group (Guernsey) Limited Company Administrator Attn: Mark Woodall Tel: +44 1481 723450 Preliminary Results, Amendment to Convertible Securities & Management Agreement and New Investment Focus Guernsey. 28 February 2013 - Eurocastle Investment Limited (Euronext Amsterdam: ECT) ("Eurocastle" or the "Company") hereby announces its preliminary results for the 12 months ended 31 December 2012. Highlights The Company expects to report that its NAV has decreased by 55.6 million (0.18 per share) to 307.3 million or 0.46 per share1 mainly as a result of share dilution reflecting interest accruing on the convertible debt (0.10 per share) and a decrease in the fair value of the Company's investment property (0.10 per share), which has been partially offset by gains realised from senior debt repurchases net of impairment losses within Eurocastle's Debt Investment portfolio. The Company has secured a 12 month extension of the senior loan on the Drive portfolio to January 2014 with interim amortisation targets to be met through an agreed sales programme. Eurocastle remains in constructive discussions with the lenders of the junior facility which matured in January 2013. As at 31 December 2012, Eurocastle had a corporate cash balance of 38.8 million. The Company proposes to clean up its capital structure by re-striking the conversion price in its outstanding Convertible Securities from 0.30 to 0.05 per share and converting all such outstanding convertible debt into ordinary shares. Conditional on such conversion, the Company has reached agreement to rebase the management fee calculation under its management agreement with FIG LLC, an affiliate of Fortress Investment Group LLC ("Fortress"), which will preserve capital for investment. The Company sees opportunities in moving its investment focus to distressed Italian debt and real estate. 1 The NAV disclosed is on a fully diluted basis and excludes the negative NAV of the Mars Floating portfolio as this financing is non-recourse to the Company and not callable as a result of any changes in the value of the assets. Summarised Balance Sheet 2012 (unaudited) '000 2011 (audited) '000 Cash and cash equivalents 141.3 117.7 Real Estate investment property 2,020.3 2,201.8 Debt investments 456.1 494.2 Other assets 31.7 57.1 Total assets 2,649.4 2,870.8 Interest bearing debt financing (2,251.0) (2,405.9) Other liabilities (106.3) (102.0) Total liabilities (2,357.3) (2,507.9) Net assets 292.1 362.9 Net assets /share 0.44 0.64 Net assets of the Mars Floating Portfolio (15.2) 5.7 Adjusted net assets2 307.3 362.9 Adjusted net assets /share 0.46 0.64 Summarised Income Statement 2012 (unaudited) '000 2011 (audited) '000 Rental and service charge income 167.7 121.1 Interest income 23.9 25.2 Net impact of sale of Mars Fixed 6.8 (9.4) Decrease in fair value of investment properties (94.7) (28.8) Other than temporary impairment on securities (16.7) (41.0) Interest expense (87.2) (80.8) Service charges and property operating expenses (57.0) (41.2) Other operating income / (expenses) (14.8) (16.1) Net (loss) / profit before taxation (71.9) (71.0) Taxation (9.7) (1.1) Net (loss) / profit after taxation (81.7) (72.1) 2 Excludes the negative net assets of the Mars Floating portfolio. The Company expects to publish its audited financial statements for the year ended 31 December 2012 in the second half of March 2013. Amendments to Convertible Securities and Management Agreement Eurocastle also announces that it has today posted to the holders of its 75,000,000 20 per cent. perpetual subordinated convertible securities (the "Series A Convertible Securities") and the holders of its 24,750,000 20 per cent. perpetual subordinated convertible securities (together with the Series A Convertible Securities, the "Convertible Securities") a notice seeking their consent to certain amendments to the conditions of the Convertible Securities. The amendments, if approved by the requisite majority of securityholders, would authorise Eurocastle to mandatorily convert all but not some of the outstanding Convertible Securities (total expected balance as at 28 February 2013 of 166.5 million) on or prior to 31 May 2013 at a Conversion Price of 0.05 per ordinary share, resulting in the issue of new ordinary shares representing in excess of 96% of the resultant aggregate number of ordinary shares in issue. The Conversion Price of 0.05 is equal to the 90 day trailing average price of the Company's ordinary shares as quoted on Euronext. If the securityholders approve the amendment to the conditions of the Convertible Securities, Eurocastle currently expects to exercise the mandatory conversion right promptly following the effective date of the amendment. Eurocastle and Fortress, its investment manager, have agreed to make certain amendments to the management and advisory agreement pursuant to which Fortress manages Eurocastle's assets, with the effectiveness of such amendments being conditional upon the conversion of all of the outstanding Convertible Securities. The agreed amendments would (i) reduce the amount payable by Eurocastle to Fortress as annual management fee by resetting the capital base upon which such fee is calculated from an amount equal to aggregate equity proceeds raised to 300 million plus an amount equal to the proceeds of any future issue of equity share capital; and (ii) similarly reset the capital base upon which Fortress's entitlement to incentive compensation is calculated. Taken together, Eurocastle believes that these measures will simplify the capital structure of the company, reduce the Company's ongoing operating costs thus freeing up additional capital for investment, and re-align the investment manager's incentives. If market conditions permit, the Company may seek to raise additional capital through the issue of further shares in order to make new investments. Subject to profits being available for the purpose, the Company also intends to resume regular dividend payments. New Investment Opportunities Concurrently, Eurocastle is intending to pursue new investment opportunities in the Italian real estate market. Fortress believes there is the potential for attractive gross unlevered returns through investment in Italian non-performing loans and other real estate assets. Fortress has had a significant presence in Italy since 2000 both as an investor in non-performing loans and through its ownership of Italfondiario, the largest independent non-performing loan servicer in Italy.
Zoals door mij reeds aangekondigd eind vorig jaar, wordt 2013 het jaar van de 'Grote Veranderingen'. Als alles volgens plan verloopt raakt ECT verlost van de converteerbare obligaties en wordt het een min of meer normaal beleggingsfonds. De jaarlijkse dumps in de periode aug t/m dec zijn hierdoor verleden tijd.. De om te wisselen aandelen zouden natuurlijk verkocht kunnen gaan worden, maar ik zie dit niet zo gauw gebeuren gezien de veel hogere (dan de koers) intrinsieke waarde. De koers kan ik niet voorspellen, maar vandaag wordt een zeer spannende dag, dat staat vast! En misschien wordt vandaag zelfs de dag waarop de verkopers uit het verleden en de niet-kopers naar de winkel hollen om een helm te kopen.....
Opmerkelijk is de stijging van rental and service change income tot 167,7 miljoen. In 2011 was dat nog 121.1 miljoen. Onder de streep werd een verlies geboekt van 81,7 miljoen, een miljoen of 10 meer dan in 2011 door afschrijvingen. De converteerbare obligatie wil ECT inwisselen in aandelen tussen de 0,30 en de 0,05 euro. Dat is positief te noemen. Je hebt dan beter overzicht. Voordat je een goed beeld kunt vormen, moet je eerst weten hoeveel aandelen erbij komen en hoe Drive afloopt. Wat wordt de impact van Drive op de resultaatvorming?
ECT sloot de eerste helft 2012 af met een klein winstje. Dat gaf enig optimisme. De jaarcijfers 2012 kwamen uit op -82 miljoen netto. Niemand kan voorspellen wat er eind 2013 op de borden staat. Wordt er niets meer afgeschreven? Wat levert de sanering bij Drive op ,op het eindresultaat? Hoe staat het ervoor na de omwisseling van de converteerbare obligatie in aandelen op 30 Juni? Dit is geen fonds om al je geld in te stoppen zolang niet alles op de rails staat. Al je geld natuurlijk niet of je moet van gokken houden. Dan zit je goed bij ECT. Van 0,04 naar 0,08 was lucratief.
De meesten hier houden van gokken. Behave Marc, maar die heeft z'n schaapjes op t droge.... Zelfs goudvinkie was met een winst van160% binnen n paar maanden toch echt niet tevreden.....
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
AIRBUS
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
CVC Capital Partners
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia Oyj
Nokia OYJ
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)
Premium
Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!
Word abonnee